Table 2.
HRQOL of different patient groups and discriminative validity of the EQ-5D-5L
| N | % |
EQ-5D Index |
VAS |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | p-value | Mean | p-value | |||||||
|
All patients |
1016 |
100.0 |
0.65 |
0.63 |
0.67 |
|
70.34 |
69.17 |
71.51 |
|
|
HIV Stages | ||||||||||
| - Asymptomatic |
126 |
12.4 |
0.73 |
0.69 |
0.77 |
<0.01 |
76.67 |
74.14 |
79.20 |
<0.01 |
| - Symptomatic |
508 |
50.0 |
0.65 |
0.63 |
0.67 |
|
70.72 |
69.15 |
72.29 |
|
| - AIDS |
382 |
37.6 |
0.62 |
0.59 |
0.66 |
|
67.79 |
65.66 |
69.91 |
|
|
CD4 | ||||||||||
| <=200 |
249 |
31.1 |
0.58 |
0.54 |
0.61 |
<0.01 |
64.47 |
61.80 |
67.14 |
<0.01 |
| 200<cd4<=350 |
249 |
31.1 |
0.66 |
0.62 |
0.69 |
|
71.62 |
69.43 |
73.81 |
|
| 350<cd4<=500 |
194 |
24.2 |
0.73 |
0.70 |
0.75 |
|
75.57 |
73.48 |
77.65 |
|
| >500 |
109 |
13.6 |
0.69 |
0.65 |
0.74 |
|
76.22 |
73.20 |
79.24 |
|
|
Duration of ART | ||||||||||
| Not yet |
114 |
11.2 |
0.64 |
0.59 |
0.69 |
<0.01 |
68.15 |
64.50 |
71.80 |
<0.01 |
| <=1 yr |
196 |
19.3 |
0.58 |
0.54 |
0.62 |
|
65.53 |
62.57 |
68.50 |
|
| 1; <=2 |
144 |
14.2 |
0.65 |
0.61 |
0.69 |
|
71.54 |
68.58 |
74.49 |
|
| 2; <=4 |
270 |
26.6 |
0.68 |
0.65 |
0.71 |
|
71.76 |
69.56 |
73.95 |
|
| 4; <=7 |
292 |
28.7 |
0.68 |
0.64 |
0.71 |
|
72.52 |
70.44 |
74.60 |
|
|
IDU | ||||||||||
| - No |
548 |
53.9 |
0.66 |
0.63 |
0.68 |
0.48 |
71.29 |
69.72 |
72.85 |
0.09 |
| - Yes |
468 |
46.1 |
0.64 |
0.62 |
0.67 |
|
69.24 |
67.46 |
71.01 |
|
|
AUDIT-positive | ||||||||||
| - No |
710 |
69.9 |
0.67 |
0.65 |
0.69 |
<0.01 |
71.73 |
70.40 |
73.07 |
<0.01 |
| - Yes |
306 |
30.1 |
0.60 |
0.57 |
0.63 |
|
67.12 |
64.78 |
69.47 |
|
|
Optimal ART adherence | ||||||||||
| - No |
660 |
75.3 |
0.65 |
0.63 |
0.67 |
0.91 |
71.15 |
69.69 |
72.62 |
0.47 |
| - Yes | 217 | 24.7 | 0.65 | 0.62 | 0.69 | 70.09 | 67.73 | 72.44 | ||